All Pharma News
Neurophth Announces Completion of Patient Enrollment for Opvika Phase I/II Trial

Neurophth Announces Completion of Patient Enrollment for Opvika Phase I/II Trial
PR NEWSWIRE
19 Feb 2024
Share Share
Neurophth Announces First Patient Dosed in Ph I/II Trial of Second Gene Therapy

Neurophth Announces First Patient Dosed in Ph I/II Trial of Second Gene Therapy
PR NEWSWIRE
17 Aug 2023
Share Share
Neurophth Secures $95M in Series C+ Financing for Clinical Trials

Neurophth Secures $95M in Series C+ Financing for Clinical Trials
CONTRACT PHARMA
14 Aug 2023
Share Share
Neurophth Completes Enrollment for PIII trial for gene therapy treatment of LHON

Neurophth Completes Enrollment for PIII trial for gene therapy treatment of LHON
PR NEWSWIRE
21 Feb 2023
Share Share
Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON

Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON
PRNEWSWIRE
19 Dec 2022
Share Share
Cyagen and Neurophth partner to develop gene therapy vectors

Cyagen and Neurophth partner to develop gene therapy vectors
PHARMACEUTICAL-TECHNOLOGY
08 Nov 2022
Share Share
China CDE Grants BTD to Neurophth`s NR082 in LHON

China CDE Grants BTD to Neurophth`s NR082 in LHON
PRNEWSWIRE
15 Jul 2022
Share Share
EMA Grants ODD to Neurophth Tx` NR082

EMA Grants ODD to Neurophth Tx` NR082
PRNEWSWIRE
25 Jan 2022
Share Share
Neurophth Tx Receives IND Clearance to Initiate Trial for NR082 in LHON

Neurophth Tx Receives IND Clearance to Initiate Trial for NR082 in LHON
PRNEWSWIRE
19 Jan 2022
Share Share
Neurophth Raised Over $60M USD in Series-C Financing to Advance Gene Therapies

Neurophth Raised Over $60M USD in Series-C Financing to Advance Gene Therapies
PRNEWSWIRE
23 Nov 2021
Share Share